123 related articles for article (PubMed ID: 76466)
1. [The role of mepartricin in the medical treatment of benign prostatic adenoma].
Casella G; Barbaro A
Arch Sci Med (Torino); 1978; 135(1):95-8. PubMed ID: 76466
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy].
Virgili G; Mearini E; Sbarberi L; Camilli P; Costantini E
Minerva Med; 1986 May; 77(20):861-6. PubMed ID: 2425285
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of benign prostatic hypertrophy using mepartricin at high dosage].
Giurioli A; Rosi P; Parziani S; Cesaroni M; Ghamari MR
Minerva Urol Nefrol; 1988; 40(2 Suppl):38-9. PubMed ID: 2460947
[No Abstract] [Full Text] [Related]
4. [Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients].
Serretta V; Pavone C; Di Trapani D; Romano C; Costa G; Caramia G
Minerva Urol Nefrol; 1988; 40(2 Suppl):55-8. PubMed ID: 2460954
[No Abstract] [Full Text] [Related]
5. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
Mirone V; Prezioso D; Palmieri A; Bocchini P
Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
[No Abstract] [Full Text] [Related]
6. [The effects of mepartricin on the symptomatology of prostatic hypertrophy--double-blind controlled trial].
Vanden Bossche M; Abi Aad A; Vandendris M; Van Cangh P; Schulman C
Acta Urol Belg; 1991; 59(1):93-104. PubMed ID: 1718154
[TBL] [Abstract][Full Text] [Related]
7. [Mepartricin in the treatment of benign prostatic hyperplasia].
Cirillo Marucco E; Pagliarulo A; Piccinno A; Di Rienzo U
Minerva Urol Nefrol; 1988; 40(2):101-4. PubMed ID: 2459784
[No Abstract] [Full Text] [Related]
8. [Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy].
Cirillo Marucco E; Giocoli Nacci G; Pagliarulo A; Balacco G; Ludovico G
Minerva Urol Nefrol; 1988; 40(2 Suppl):23-4. PubMed ID: 2460941
[No Abstract] [Full Text] [Related]
9. [Clinical and echographic evaluation of a group of 40 patients suffering from benign prostatic hypertrophy treated with mepartricin].
Alei G
Minerva Urol Nefrol; 1988; 40(2 Suppl):59-61. PubMed ID: 2460955
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of mepartricin in benign prostatic hypertrophy].
Giannotti P; Murzi P; Marconi A; Pistolesi D; Morelli G
Minerva Urol Nefrol; 1988; 40(3):175-80. PubMed ID: 2467388
[No Abstract] [Full Text] [Related]
11. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Open study of 39 patients].
Montanari E; Patelli E; Mandressi A; Magri V; Pisani E
Minerva Urol Nefrol; 1988; 40(2 Suppl):25-9. PubMed ID: 2460942
[No Abstract] [Full Text] [Related]
12. [The effect of mepartricin on prostatic adenoma].
Pellet B; Granata F; von Niederhäusern W
Rev Med Suisse Romande; 1980 Nov; 100(11):899-903. PubMed ID: 6162182
[No Abstract] [Full Text] [Related]
13. [Evaluation of the pharmacological effect of mepartricin in urological pathology by prostatic superficial echotomography].
Gasparini-Casari M; Palmieri B; Noera G; Ferrari P
Minerva Urol; 1980; 32(1):5-10. PubMed ID: 6155599
[No Abstract] [Full Text] [Related]
14. [Medical treatment of benign prostatic hypertrophy. Echographic evaluation].
Traficante A; Martino P; Battaglia M
Minerva Urol Nefrol; 1988; 40(2 Suppl):47-9. PubMed ID: 2460950
[No Abstract] [Full Text] [Related]
15. [Latest contribution concerning the use of mepartricin in adenoma of the prostate].
Comar OB; Di Rienzo A
Minerva Urol Nefrol; 1988; 40(2 Suppl):30-2. PubMed ID: 2460944
[No Abstract] [Full Text] [Related]
16. [Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trial].
Pagliano FM
Arch Sci Med (Torino); 1979; 136(2):303-8. PubMed ID: 391176
[TBL] [Abstract][Full Text] [Related]
17. [Use of mepartricin in the patient suffering from so-called benign prostatic hypertrophy. Study of 142 cases].
Fiorilla C
Minerva Urol Nefrol; 1988; 40(2 Suppl):35-7. PubMed ID: 2460946
[No Abstract] [Full Text] [Related]
18. [Mepartricin versus placebo in the therapy of prostatic hypertrophy].
Fini M; Perrone A; Ferraresi R; Salvi G; Misuriello G; Vagliani GF
Minerva Urol Nefrol; 1988; 40(2 Suppl):53-4. PubMed ID: 2460953
[No Abstract] [Full Text] [Related]
19. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Evaluation of clinical and functional parameters].
Petrone U; Gaspari G; Magnocavallo N; Petrone D; Tucci C; Marascia G
Minerva Urol Nefrol; 1988; 40(2):89-91. PubMed ID: 2459785
[No Abstract] [Full Text] [Related]
20. [Double-blind study on the effects of mepartricin (SPA-S-160) versus placebo in the treatment of obstruction caused by adenoma of the prostate].
Rizzo M; Tosto A; Dattolo E; Serni S
Minerva Urol Nefrol; 1988; 40(2 Suppl):21-2. PubMed ID: 2460940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
